KOD Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $94.45

Capitalizzazione di Mercato (MRQ) $5.93B

P/E -21.9

EPS $-4.32

ROE -202.0%

Intervallo 52 sett. $11–$104

KOD Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Kodiak Sciences Inc - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaBiotechnology dipendenti141 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

EPS$-4.32

2020-12-31 → 2025-12-31

Flusso di cassa libero$-137M

2018-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	KOD	media 5 anni	Mediana dei peer	Verdetto
P/E	-21.9media 5 anni ≈-5.5	≈-5.5	·	·
P/B (MRQ)	97.1media 5 anni ≈4.5	≈4.5	12.5	Sopravvalutato
Prezzo / FCF (TTM)	-37.1media 5 anni ≈-8.3	≈-8.3	·	·
Prezzo / Flusso di cassa (TTM)	-37.4media 5 anni ≈-8.8	≈-8.8	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	37.1media 5 anni ≈4.5	≈4.5	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	KOD	media 5 anni	Mediana dei peer	Verdetto
ROA	-66.9%media 5 anni ≈-45.0%	≈-45.0%	-23.8%	Debole
ROE	-202.0%media 5 anni ≈-102.0%	≈-102.0%	-56.0%	Debole
ROIC	-149.0%media 5 anni ≈-99.2%	≈-99.2%	-55.8%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	KOD	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		2.5media 5 anni ≈7.8	≈7.8	4.3	Bassa liquidità
Quick Ratio		4.6media 5 anni ≈7.7	≈7.7	3.1	Bassa liquidità

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	KOD	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-4.32media 5 anni ≈$-4.84	≈$-4.84	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-2.56media 5 anni ≈$-2.92	≈$-2.92	·	·
Cash / Share (Liquidità / Azione)	$3.40media 5 anni ≈$5.96	≈$5.96	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media -2.9%

Prossimo report Nov 11, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 13, 2026	$-1.05	$-0.97	-8.7%
31 Marzo 2026	Mag 20, 2026	$-0.94	$-1.02	8.1%
31 Dicembre 2025		$-1.04	$-1.06	2.2%
30 Settembre 2025		$-1.16	$-1.04	-11.6%
30 Giugno 2025		$-1.03	$-1.08	4.4%
31 Marzo 2025		$-1.09	$-0.90	-20.7%
31 Dicembre 2024		$-0.84	$-0.89	6.0%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 15

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
R&D Expense	$182M	$126M	$206M	$268M	$217M	$107M	$38M	$19M	$22M
SG&A Expense	$52M	$61M	$71M	$74M	$50M	$29M	$12M	$8M	$3M
Operating Expenses	$234M	$187M	$277M	$341M	$267M	$136M	$49M	$26M	$26M
Operating Income	$-234M	$-187M	$-277M	$-341M	$-267M	$-136M	$-49M	$-26M	$-26M
Interest Expense	$0	$0	$13.0K	$18.0K	$47.0K	$25.0K	$8.0K	$6M	$1M
Interest Income	$5M	$11M	$17M	$7M	$298.0K	$3M	$2M	$617.0K	$29.0K
Other Non-op	$-96.0K	$-506.0K	$110.0K	$503.0K	$-190.0K	$-30.0K	$265.0K	$-5M	$-1M
Pretax Income	$-230M	$-176M	$-260M	$-334M	$-267M	$-133M	$-47M	$-41M	$-28M
Income Tax	$52.0K	$20.0K	$33.0K	$33.0K	$74.0K	$14.0K	·	·	·
Net Income	$-230M	$-176M	$-260M	$-334M	$-267M	$-133M	$-47M	$-41M	$-28M
EPS (Basic)	$-4.32	$-3.35	$-4.97	$-6.39	$-5.16	$-2.91	·	·	·
EPS (Diluted)	$-4.32	$-3.35	$-4.97	$-6.39	$-5.16	$-2.91	·	·	·
Shares (Basic)	53,208,311	52,583,148	52,414,256	52,249,620	51,788,918	45,741,845	·	·	·
Shares (Diluted)	53,208,311	52,583,148	52,414,256	52,249,620	51,788,918	45,741,845	·	·	·
EBITDA	$-234M	$-187M	$-277M	$-341M	$-267M	$-136M	$-49M	$-26M	·

Stato Patrimoniale 21

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$210M	$168M	$286M	$190M	$732M	$944M	$212M	$88M	$1M
Short-term Investments	·	·	$0	$288M	$0	$25M	$125M	·	·
Prepaid Expense	$5M	$4M	$4M	$7M	$3M	$3M	$3M	$2M	$200.0K
Current Assets	$215M	$172M	$289M	$486M	$735M	$972M	$339M	$90M	$2M
PP&E (Net)	$85M	$102M	$120M	$56M	$41M	$5M	$996.0K	$1M	$2M
PP&E (Gross)	$145M	$143M	$143M	$63M	$44M	$7M	$3M	$3M	$3M
Accum. Depreciation	$59M	$41M	$23M	$7M	$3M	$2M	$2M	$2M	$1M
Other Non-current Assets	$9M	$9M	$9M	$59M	$55M	$10M	$5M	$503.0K	·
Total Assets	$352M	$336M	$479M	$667M	$904M	$1.07B	$359M	$92M	$3M
Accounts Payable	$13M	$4M	$14M	$9M	$12M	$9M	$3M	$1M	$3M
Accrued Liabilities	$21M	$11M	$18M	$33M	$48M	$20M	$9M	$4M	$6M
Current Liabilities	$46M	$26M	$42M	$52M	$65M	$31M	$12M	$5M	$9M
Capital Leases	$47M	$60M	$72M	$78M	$76M	$75M	$2M	·	·
Other Non-current Liabilities	·	·	$0	$162.0K	$211.0K	$256.0K	$295.0K	$530.0K	$586.0K
Total Liabilities	$194M	$185M	$214M	$230M	$241M	$207M	$14M	$5M	$22M
Common Stock	$6.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$4.0K	$1.0K
Retained Earnings	$-1.56B	$-1.33B	$-1.15B	$-892M	$-558M	$-291M	$-158M	$-111M	$-69M
AOCI	·	·	$0	$-1M	$0	$53.0K	$10.0K	·	·
Stockholders' Equity	$157M	$150M	$266M	$436M	$663M	$861M	$345M	$87M	$-69M
Liabilities + Equity	$352M	$336M	$479M	$667M	$904M	$1.07B	$359M	$92M	$3M
Shares Outstanding	61,758,454	52,726,916	52,508,602	52,333,850	51,826,257	51,112,302	44,413,404	36,829,857	7,936,434

Flusso di cassa 12

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Stock-based Comp	$59M	$60M	$89M	$106M	$61M	$31M	$6M	$3M	$275.0K
Deferred Tax	·	$0	$0	$0	$0	$0	·	·	·
Operating Cash Flow	$-136M	$-117M	$-154M	$-206M	$-182M	$-83M	$-39M	$-29M	$-18M
CapEx	$506.0K	$375.0K	$41M	$37M	$17M	$4M	$437.0K	$78.0K	$209.0K
Investing Cash Flow	$-506.0K	$-755.0K	$249M	$-337M	$-39M	$105M	$-137M	$-581.0K	$-209.0K
Stock Issued	·	·	·	$0	$0	$612M	$298M	$84M	·
Stock Repurchased	·	·	·	·	·	·	·	$0	$0
Net Stock Activity	·	·	·	$0	·	$612M	$298M	$84M	·
Financing Cash Flow	$178M	$501.0K	$31.0K	$2M	$8M	$717M	$300M	$116M	$10M
Taxes Paid	$0	$0	$0	·	·	·	·	·	·
Free Cash Flow	$-137M	$-118M	$-196M	$-243M	$-199M	$-87M	$-40M	$-29M	·
Levered FCF	$-137M	$-118M	$-196M	$-243M	$-199M	$-87M	·	·	·

Redditività 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
ROA	-66.9%	-43.2%	-45.5%	-42.5%	-27.1%	-18.7%	-21.0%	-86.9%	·
ROE	-202.0%	-105.0%	-91.7%	-72.9%	-38.4%	-23.3%	-23.4%	1184.6%	·
ROIC	-149.0%	-124.3%	-104.3%	-78.3%	-40.3%	-15.8%	·	·	·

Liquidità e Solvibilità 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	4.7	6.7	6.9	9.3	11.4	30.9	29.0	18.7	·
Quick Ratio	4.6	6.6	6.8	9.1	11.3	30.8	28.7	18.3	·
Interest Coverage	·	·	-21332.4	-18965.5	-12138.7	-5440.3	-6148.8	-4.8	·

Per Azione 4

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$2.55	$2.86	$5.06	$8.33	$12.80	$16.84	$7.78	$2.36	·
Cash Flow / Share	$-2.56	$-2.23	$-2.94	$-3.95	·	·	·	·	·
Cash / Share	$3.40	$3.20	$5.44	$3.64	$14.11	$18.48	$4.77	$2.40	·
EPS (TTM)	$-4.32	$-3.35	$-4.97	$-6.39	$-5.16	$-2.91	·	·	·

Valutazione (TTM) 8

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Net Income TTM	$-230M	$-176M	$-260M	$-334M	$-267M	$-133M	$-47M	$-41M	·
Market Cap	$1.73B	$522M	$160M	$375M	$4.39B	$7.51B	$3.20B	$261M	·
P/E	-6.5	-3.0	-0.6	-1.1	-16.4	-50.5	·	·	·
P/B	11.0	3.5	0.6	0.9	6.6	8.7	9.3	3.0	·
P / Tangible Book	11.0	3.5	0.6	0.9	6.6	8.7	·	·	·
P / Cash Flow	-12.7	-4.5	-1.0	-1.8	-24.1	-90.0	-81.6	-9.0	·
P / FCF	-12.6	-4.4	-0.8	-1.5	-22.0	-86.1	-80.7	-9.0	·
Earnings Yield	-15.4%	-33.7%	-163.5%	-89.2%	-6.1%	-2.0%	·	·	·

Conto Economico 13

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
R&D Expense	$56M	$49M	$45M	$50M	$43M	$44M	$32M	$32M	$33M	$30M	$36M	$67M	$57M	$62M	$74M	$76M
SG&A Expense	$11M	$11M	$12M	$12M	$13M	$15M	$14M	$15M	$15M	$16M	$18M	$18M	$18M	$18M	$18M	$20M
Operating Expenses	$67M	$60M	$57M	$62M	$56M	$59M	$46M	$47M	$48M	$46M	$54M	$85M	$75M	$79M	$92M	$96M
Operating Income	$-67M	$-60M	$-57M	$-62M	$-56M	$-59M	$-46M	$-47M	$-48M	$-46M	$-54M	$-85M	$-75M	$-79M	$-92M	$-96M
Interest Expense	·	·	·	·	·	·	$0	$0	$0	$0	$5.0K	$4.0K	$4.0K	$4.0K	$5.0K	$5.0K
Interest Income	$1M	$2M	$757.0K	$917.0K	$1M	$2M	$2M	$3M	$3M	$3M	$5M	$5M	$4M	$2M	$1M	$76.0K
Other Non-op	$-60.0K	$-22.0K	$-40.0K	$-22.0K	$-44.0K	$10.0K	$-56.0K	$-25.0K	$-88.0K	$-337.0K	$-38.0K	$-35.0K	$222.0K	$-40.0K	$-49.0K	$-13.0K
Net Income	$-66M	$-58M	$-57M	$-61M	$-54M	$-57M	$-44M	$-44M	$-45M	$-43M	$-50M	$-80M	$-71M	$-77M	$-91M	$-96M
EPS (Basic)	$-1.05	$-0.94	$-1.04	$-1.16	$-1.03	$-1.09	$-0.83	$-0.84	$-0.86	$-0.82	$-0.95	$-1.53	$-1.35	$-1.47	$-1.74	$-1.83
EPS (Diluted)	$-1.05	$-0.94	$-1.04	$-1.16	$-1.03	$-1.09	$-0.83	$-0.84	$-0.86	$-0.82	$-0.95	$-1.53	$-1.35	$-1.47	$-1.74	$-1.83
Shares (Basic)	62,628,596	61,859,485	·	52,859,308	52,779,162	52,746,318	·	52,616,183	52,554,215	52,510,460	52,455,620	52,378,729	52,337,603	52,288,257	52,218,773	52,172,918
Shares (Diluted)	62,628,596	61,859,485	·	52,859,308	52,779,162	52,746,318	·	52,616,183	52,554,215	52,510,460	52,455,620	52,378,729	52,337,603	52,288,257	52,218,773	52,172,918
EBITDA	$-67M	$-60M	·	$-62M	$-56M	$-59M	·	$-47M	$-48M	$-46M	$-54M	$-85M	$-75M	$-79M	$-92M	$-96M

Stato Patrimoniale 21

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$126M	$170M	$210M	$72M	$104M	$139M	$168M	$198M	$219M	$246M	$346M	$379M	$317M	$178M	$173M	$672M
Short-term Investments	·	·	·	·	·	·	·	·	·	·	$0	$0	$105M	$359M	$425M	·
Prepaid Expense	$5M	$6M	$5M	$4M	$4M	$4M	$4M	$5M	$5M	$6M	$5M	$8M	$10M	$7M	$6M	$10M
Current Assets	$131M	$175M	$215M	$76M	$108M	$143M	$172M	$202M	$225M	$252M	$351M	$387M	$431M	$545M	$604M	$682M
PP&E (Net)	$78M	$82M	$85M	$89M	$93M	$98M	$102M	$107M	$111M	$116M	$125M	$130M	$135M	$56M	$55M	$49M
PP&E (Gross)	·	·	$145M	·	·	·	$143M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$59M	·	·	·	$41M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$56M	$54M	$48M
Total Assets	$257M	$306M	$352M	$218M	$257M	$298M	$336M	$373M	$402M	$435M	$548M	$590M	$640M	$724M	$782M	$850M
Accounts Payable	$13M	$11M	$13M	$10M	$5M	$7M	$4M	$3M	$2M	$2M	$39M	$12M	$6M	$16M	$21M	$13M
Accrued Liabilities	$30M	$27M	$21M	$20M	$15M	$13M	$11M	$11M	$9M	$13M	$23M	$54M	$55M	$41M	$43M	$58M
Current Liabilities	$53M	$50M	$46M	$42M	$31M	$31M	$26M	$24M	$21M	$25M	$71M	$74M	$69M	$66M	$70M	$76M
Capital Leases	$43M	$44M	$47M	$50M	$54M	$57M	$60M	$63M	$66M	$69M	$74M	$77M	$79M	$79M	$81M	$76M
Other Non-current Liabilities	·	·	·	·	·	·	·	·	·	·	$0	$0	$0	$175.0K	$187.0K	$199.0K
Total Liabilities	$196M	$194M	$194M	$194M	$186M	$189M	$185M	$187M	$187M	$194M	$245M	$251M	$248M	$244M	$251M	$253M
Common Stock	$6.0K	$6.0K	$6.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K
Retained Earnings	$-1.68B	$-1.62B	$-1.56B	$-1.50B	$-1.44B	$-1.39B	$-1.33B	$-1.28B	$-1.24B	$-1.20B	$-1.09B	$-1.04B	$-963M	$-822M	$-745M	$-654M
AOCI	·	·	·	·	·	·	·	·	·	·	$0	$0	$-96.0K	$-3M	$-2M	·
Stockholders' Equity	$61M	$112M	$157M	$24M	$70M	$109M	$150M	$185M	$215M	$241M	$302M	$338M	$393M	$480M	$531M	$597M
Liabilities + Equity	$257M	$306M	$352M	$218M	$257M	$298M	$336M	$373M	$402M	$435M	$548M	$590M	$640M	$724M	$782M	$850M
Shares Outstanding	62,830,860	62,155,685	61,758,454	52,998,561	52,821,689	52,751,875	52,726,916	52,623,087	52,614,729	52,523,447	52,467,291	52,453,163	52,344,741	52,304,154	52,024,621	51,939,881

Flusso di cassa 6

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Stock-based Comp	$12M	$12M	$13M	$14M	$16M	$16M	$9M	$15M	$18M	$18M	$14M	$26M	$26M	$26M	$26M	$28M
Operating Cash Flow	$-46M	$-40M	$-39M	$-33M	$-35M	$-29M	$-30M	$-21M	$-26M	$-40M	$-33M	$-42M	$-47M	$-53M	$-55M	$-43M
CapEx	$352.0K	$942.0K	$43.0K	$60.0K	$133.0K	$270.0K	$124.0K	$180.0K	$49.0K	$22.0K	$226.0K	$1M	$12M	$8M	$8M	$17M
Investing Cash Flow	$-352.0K	$-942.0K	$-43.0K	$-60.0K	$-133.0K	$-270.0K	$-124.0K	$-205.0K	$-260.0K	$-166.0K	$-226.0K	$104M	$173M	$59M	$-444M	$-18M
Financing Cash Flow	$3M	$619.0K	$177M	$813.0K	$120.0K	$124.0K	$404.0K	$0	$59.0K	$38.0K	$-12.0K	$170.0K	$-3.0K	$78.0K	$54.0K	$2M
Free Cash Flow	·	$-41M	·	·	·	$-29M	·	·	·	$-40M	·	·	$-59M	·	·	$-61M

Redditività 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
ROA		-25.6%	-19.3%	·	-20.8%	-16.5%	-15.7%	·	-9.6%	-9.1%	-8.0%	-7.9%	-11.7%	-9.5%	-9.2%	-10.2%	-10.2%
ROE		-99.9%	-52.6%	·	-58.8%	-38.1%	-32.8%	·	-18.0%	-16.3%	-13.6%	-12.8%	-18.4%	-14.3%	-12.8%	-13.8%	-13.5%

Liquidità e Solvibilità 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Current Ratio	2.5	3.5	·	1.8	3.5	4.6	·	8.4	10.6	10.1	5.0	5.2	6.3	8.3	8.7	8.9
Quick Ratio	2.4	3.4	·	1.7	3.4	4.5	·	8.2	10.3	9.9	4.9	5.1	6.1	8.2	8.6	8.8
Interest Coverage	·	·	·	·	·	·	·	·	·	·	-10900.0	-21208.0	-18653.8	-19869.5	-18413.6	-19153.4

Per Azione 4

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$0.97	$1.80	·	$0.45	$1.33	$2.06	·	$3.52	$4.08	$4.59	$5.76	$6.45	$7.50	$9.17	$10.21	$11.50
Cash Flow / Share	·	$-0.65	·	·	·	$-0.55	·	·	·	$-0.75	·	·	$-0.90	·	·	·
Cash / Share	$2.00	$2.73	·	$1.36	$1.97	$2.63	·	$3.76	$4.17	$4.68	$6.59	$7.22	$6.05	$3.41	$3.32	$12.93
EPS (TTM)	$-4.19	$-4.17	·	$-4.11	$-3.79	$-3.62	·	$-3.66	$-3.77	$-4.44	$-5.18	$-5.70	$-5.91	$-6.84	$-6.67	$-6.01

Valutazione (TTM) 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Net Income TTM	$-242M	$-231M	·	$-217M	$-200M	$-191M	·	$-192M	$-198M	$-233M	$-271M	$-298M	$-309M	$-357M	$-347M	$-312M
Market Cap	$2.45B	$2.37B	·	$868M	$197M	$148M	·	$137M	$124M	$276M	$94M	$362M	$325M	$405M	$397M	$401M
P/E	-9.3	-9.1	·	-4.0	-1.0	-0.8	·	-0.7	-0.6	-1.2	-0.3	-1.2	-1.0	-1.1	-1.1	-1.3
P/B	40.1	21.1	·	36.6	2.8	1.4	·	0.7	0.6	1.1	0.3	1.1	0.8	0.8	0.7	0.7
P / Tangible Book	40.1	21.1	·	36.6	2.8	1.4	·	0.7	0.6	1.1	0.3	1.1	0.8	0.8	0.7	0.7
P / Cash Flow	·	-59.2	·	·	·	-5.1	·	·	·	-7.0	·	·	-6.9	·	·	-9.3
Earnings Yield	-10.8%	-10.9%	·	-25.1%	-101.6%	-128.8%	·	-140.2%	-160.4%	-84.4%	-287.8%	-82.6%	-95.3%	-88.4%	-87.3%	-77.8%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Utile netto	$-230M	$-176M	$-260M	$-334M	$-267M
EPS Diluito	$-4.32	$-3.35	$-4.97	$-6.39	$-5.16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	4.7	6.7	6.9	9.3	11.4
Quick Ratio	4.6	6.6	6.8	9.1	11.3

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-137M	$-118M	$-196M	$-243M	$-199M

Proprietari istituzionali (13F) 214 filer · $2.3B totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 214

Valore detenuto $2.3B

Nuove posizioni 34

Posizioni chiuse 22

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
34 (-30 vs trimestre precedente)	22 (+4 vs trimestre precedente)	90 (+21 vs trimestre precedente)	59 (+7 vs trimestre precedente)	+1.6M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
BAKER BROS. ADVISORS LP	$776.051.487	19.919.186	34,06%	Azioni
BlackRock, Inc.	$161.113.431	4.135.355	7,07%	Azioni
STATE STREET CORP	$94.260.486	2.419.417	4,14%	Azioni
GOLDMAN SACHS GROUP INC	$90.231.905	2.316.014	3,96%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$70.308.463	1.804.632	3,09%	Azioni
BRAIDWELL LP	$69.633.909	1.787.318	3,06%	Azioni
VANGUARD GROUP INC	$64.682.524	2.313.395	2,84%	Azioni
RTW INVESTMENTS, LP	$57.969.909	1.487.934	2,54%	Azioni
Boxer Capital Management, LLC	$57.567.296	1.477.600	2,53%	Azioni
TCG Crossover Management, LLC	$56.318.161	1.445.538	2,47%	Azioni
JANUS HENDERSON GROUP PLC	$50.539.675	1.325.457	2,22%	Azioni
ICONIQ Capital, LLC	$49.345.294	1.266.563	2,17%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$41.420.974	1.062.955	1,82%	Azioni
Ikarian Capital, LLC	$41.287.080	1.059.730	1,81%	Azioni
Artisan Partners Limited Partnership	$37.714.722	968.037	1,66%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$30.919.164	793.613	1,36%	Azioni
Board of Trustees of The Leland Stanford Junior University	$26.951.242	691.767	1,18%	Azioni
SILVERARC CAPITAL MANAGEMENT, LLC	$21.282.134	546.256	0,93%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$20.758.628	532.819	0,91%	Azioni
ADAGE CAPITAL PARTNERS GP, L.L.C.	$19.480.000	500.000	0,85%	Azioni
Squadron Capital Management LLC	$19.480.000	500.000	0,85%	Azioni
TWO SIGMA INVESTMENTS, LP	$18.428.119	473.001	0,81%	Azioni
MORGAN STANLEY	$16.948.748	435.029	0,74%	Azioni
BANK OF AMERICA CORP /DE/	$14.949.303	383.709	0,66%	Azioni
BOONE CAPITAL MANAGEMENT LLC	$14.727.270	378.010	0,65%	Azioni
NORTHERN TRUST CORP	$14.291.579	366.827	0,63%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$13.949.862	358.056	0,61%	Azioni
DIMENSIONAL FUND ADVISORS LP	$12.174.462	312.595	0,53%	Azioni
VANGUARD FIDUCIARY TRUST CO	$11.375.112	291.969	0,50%	Azioni
FMR LLC	$10.791.298	276.984	0,47%	Azioni
BOOTHBAY FUND MANAGEMENT, LLC	$10.344.815	265.524	0,45%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$9.346.504	239.900	0,41%	Opzione Call
DIADEMA PARTNERS LP	$8.497.838	218.117	0,37%	Azioni
Ikarian Capital, LLC	$8.481.592	217.700	0,37%	Opzione Call
D. E. Shaw & Co., Inc.	$8.232.248	211.300	0,36%	Azioni
DIADEMA PARTNERS LP	$7.663.432	196.700	0,34%	Opzione Call
TD Asset Management Inc	$7.563.383	194.132	0,33%	Azioni
PFM Health Sciences, LP	$7.531.552	193.315	0,33%	Azioni
UBS Group AG	$7.406.880	190.115	0,33%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$7.371.232	189.200	0,32%	Azioni
ALGERT GLOBAL LLC	$7.265.105	186.476	0,32%	Azioni
Nuveen, LLC	$6.807.481	174.730	0,30%	Azioni
CITADEL ADVISORS LLC	$6.137.135	157.524	0,27%	Azioni
Squarepoint Ops LLC	$5.886.778	151.098	0,26%	Azioni
Ghisallo Capital Management LLC	$5.844.000	150.000	0,26%	Azioni
DIADEMA PARTNERS LP	$5.723.224	146.900	0,25%	Opzione Put
Bruce & Co., Inc.	$5.649.200	145.000	0,25%	Azioni
FEDERATED HERMES, INC.	$5.612.772	144.065	0,25%	Azioni
PRUDENTIAL FINANCIAL INC	$4.694.485	120.495	0,21%	Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$4.444.907	114.089	0,20%	Azioni

Mostra tutti i 214 proprietari istituzionali →

Attivisti e proprietari del 5%+ 2 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Baker Bros. Advisors (GP) LLC, Baker Bros. Advisors LP, Felix J. Baker, Julian C. Baker	30 Settembre 2026	35,00%	Modifica	Investimento passivo	SEC
Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×12 depositi	19 Dicembre 2025	32,80%	Modifica	Struttura del capitale	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 9 insider · 4 dirigenti · 6 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Victor Perlroth	Chairman and CEO	25 Settembre 2026 M	3.676.062	0	$0
John A. Borgeson	Chief Financial Officer	15 Luglio 2026 A	211.930	6	$-2.220.497
Jason Ehrlich	Chief Medical Officer and Chief Development Officer	24 Giugno 2023 A	61.924	0	$0
Hong Liang	SVP, Discovery Medicine	02 Aprile 2020 S	130.166	0	$0
Bassil I Dahiyat	Direttore	30 Giugno 2026 A	·	0	$0
Charles A Bancroft	Direttore	30 Giugno 2026 A	·	0	$0
Richard S Levy	Direttore	30 Giugno 2026 A	1.000	0	$0
Taiyin Yang	Direttore	30 Giugno 2026 A	·	0	$0
Robert Profusek	Direttore	30 Giugno 2026 A	·	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 29 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
BBC · ETFis Series Trust I	0,82%	9.125 NS	31 Luglio 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,43%	50.808 NS	31 Luglio 2026	N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust …	0,41%	4.423 SH	02 Ottobre 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,14%	38.803 SH	02 Ottobre 2026	Giornaliero
IBB · iShares Trust	0,14%	443.467 SH	11 Settembre 2026	Giornaliero
VFMO · VANGUARD WELLINGTON FUND	0,14%	70.377 SH	19 Agosto 2026	Giornaliero
PWS · Pacer Funds Trust	0,12%	694 NS	31 Luglio 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0,09%	42.202 SH	19 Agosto 2026	Giornaliero
IWO · iShares Trust	0,08%	369.841 SH	11 Settembre 2026	Giornaliero
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,06%	10.682 NS	31 Luglio 2026	N-PORT
RSSL · Global X Funds	0,05%	18.846 NS	31 Luglio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,05%	226.556 SH	19 Agosto 2026	Giornaliero
IWM · iShares Trust	0,04%	1.011.605 SH	11 Settembre 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,02%	475.491 SH	19 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,02%	93.063 SH	19 Agosto 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,02%	14.697 NS	31 Luglio 2026	N-PORT
WSML · iShares Trust	0,01%	1.802 SH	11 Settembre 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,01%	23.200 NS	31 Luglio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	3.093 NS	31 Luglio 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	8.843 NS	31 Luglio 2026	N-PORT
IWV · iShares Trust	0,00%	14.520 SH	10 Settembre 2026	Giornaliero
ITOT · iShares Trust	0,00%	61.260 SH	11 Settembre 2026	Giornaliero
DFUS · Dimensional ETF Trust	0,00%	4.260 NS	31 Luglio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	1.288.755 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	3.260 SH	19 Agosto 2026	Giornaliero
DXUV · Dimensional ETF Trust	0,00%	4 NS	31 Luglio 2026	N-PORT
ISCB · iShares Trust	·	1.789 SH	11 Settembre 2026	Giornaliero
ISCV · iShares Trust	·	8.719 SH	11 Settembre 2026	Giornaliero
SMLF · iShares Trust	·	15.858 SH	11 Settembre 2026	Giornaliero

KOD Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 10 analisti COMPRA

Target mediano $116.00 +22,8%

2 20,0% Acquisto forte

7 70,0% Compra

1 10,0% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

6 analisti · 2026-10-03

Target medio $116.67 +23,5%

← Sotto tutti i target Prezzo attuale $94.45

Basso$96.00 Media$116.67 Alto$145.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
KOD	$1.73B	-6.5	·	·	-202.0%	·
RYTM	$7.19B	-34.4	45.8%	-103.6%	-309.1%	·
IOVA	$1.12B	-2.5	60.6%	-148.4%	-56.0%	·
GRAL	$3.45B	-7.7	17.2%	-277.5%	-16.7%	·
CGON	$3.35B	-20.0	254.7%	-3985.0%	-22.6%	·
SRRK	$4.78B	-13.4	·	·	-157.9%	·
ORKA	$1.48B	-3.3	·	·	-25.9%	·
COGT	$5.72B	-16.4	·	·	-83.1%	·
TVTX	$3.47B	-131.8	110.5%	-5.2%	-34.6%	·
MIRM	$4.10B	-168.1	54.7%	-4.5%	-8.2%	·
PTCT	$6.19B	9.8	114.5%	39.4%	-331.5%	·

Ultime notizie Notizie recenti che menzionano questa società

23

Why Kodiak Sciences Skyrocketed Today Nasdaq · 4 giorni, 17 ore fa Kodiak Sciences Inc (KOD): Qual è la probabilità di successo per Zenkuda? Yahoo Finance · 5 mesi, 1 settimana fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

KOD Kodiak Sciences Inc - Common Stock